Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
HealthcareAdd-on
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Panthera Biopartners announced it has acquired OEC, described as Hungary’s leading clinical research organisation, to expand its European footprint. The deal is positioned as a platform expansion in healthcare services.
The provided materials do not disclose deal value, closing timing, or the specific transaction structure beyond the acquisition announcement. OEC is characterized as a clinical research organisation based in Hungary.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026